James M. Mock - Feb 28, 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Financial Officer
Signature
/s/ James Dillon, As Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Feb 28, 2025
Transactions value $
-$4,974
Form type
4
Date filed
3/3/2025, 04:49 PM
Previous filing
Feb 28, 2025
Next filing
Apr 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +329 +2.24% 15K Feb 28, 2025 Direct F1
transaction MRNA Common Stock Tax liability -$4.97K -160 -1.06% $31.09 14.9K Feb 28, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -329 -11.12% $0.00 2.63K Feb 28, 2025 Common Stock 329 Direct F1, F3
transaction MRNA Stock Option (Right to Buy) Award $0 +63.5K $0.00 63.5K Mar 1, 2025 Common Stock 63.5K $30.96 Direct F4
transaction MRNA Restricted Stock Units Award $0 +39.6K $0.00 39.6K Mar 1, 2025 Common Stock 39.6K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4 25% of this option will vest and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F5 25% of the shares subject to this restricted stock unit award will vest on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.